How artificial intelligence can enhance diagnostic confidenceNovember 1, 2025In the right context, AI yields the power to enhance clinical confidence and streamline decision-making – without replacing the human touch that defines the profession.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill’s GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More
Rethinking Our Approach to Canine OA: Treating synovial inflammationOctober 1, 2025It’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
A Simpler Way to Support Clients — And Your Bottom LineAugust 11, 2025How Paw Prosper Rewards is Changing the Way Professionals Recommend Products
A "new frontier" for in-clinic veterinary cancer screeningJuly 7, 2025Cancer screening can be a stressful time for clients. However, deep learning artificial intelligence (AI) is changing the game for cytology. AI Masses – a new addition to Zoetis’s Vetscan Imagyst® platform – offers veterinarians analysis of potentially cancerous cells at the point of care, for more timely and individualized diagnosis and treatment.
A New Way Forward in Canine Osteoarthritis: Targeting Pain and Inflammation at Its SourceJuly 1, 2025The traditional approach to canine osteoarthritis (OA) has largely focused on treatments such as NSAIDs, joint supplements, stem cell, PRP, and anti-nerve growth factor (anti-NGF) injections. This raises a critical question: What if we could do more than manage symptoms? What if we could target the inflammation driving the disease?
